Le Lézard
Classified in: Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

indie Semiconductor Sets Date for First Quarter 2024 Earnings Release and Conference Call


indie Semiconductor (Nasdaq: INDI), an Autotech solutions innovator, plans to conduct a conference call with analysts to discuss its first quarter 2024 results and business outlook on May 9, 2024 at 5:00 p.m. Eastern time.

After the close of the market on May 9 and prior to the conference call, indie will issue a copy of the earnings press release via Business Wire. The press release may also be viewed on indie's website at https://investors.indiesemi.com/news.

To listen to the conference call via the Internet, please go to the Financials tab on the Investors page of indie's website. To listen to the conference call via telephone, please call (888) 886-7786 (domestic) or (416) 764-8658 (international), Conference ID: 34978665.

A replay of the conference call will be available beginning at 9:00 p.m. Eastern time on May 9, 2024, until 11:59 p.m. Eastern time on May 23, 2024, under the Financials tab on the Investors page of indie's website, or by calling (844)-512-2921 (domestic) or (412)-317-6671 (international), Access ID: 34978665.

About indie
indie is empowering the Autotech revolution with next generation automotive semiconductors and software platforms. We focus on developing innovative, high-performance and energy-efficient technology for ADAS, user experience and electrification applications. Our mixed-signal SoCs enable edge sensors spanning Radar, LiDAR, Ultrasound, and Computer Vision, while our embedded system control, power management and interfacing solutions transform the in-cabin experience and accelerate increasingly automated and electrified vehicles. We are an approved vendor to Tier 1 partner and our solutions can be found in marquee automotive OEMs worldwide. Headquartered in Aliso Viejo, CA, indie has design centers and regional support offices across the United States, Canada, Argentina, Scotland, Germany, Hungary, Morocco, India, Israel, Japan, South Korea, Switzerland, Taiwan and China.

Please visit us at www.indiesemi.com to learn more.


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: